
pmid: 29705511
Aged, 80 and over, Graft Rejection, Male, Graft Survival, Programmed Cell Death 1 Receptor, Antibodies, Monoclonal, Middle Aged, Antibodies, Monoclonal, Humanized, Ipilimumab, Kidney Transplantation, B7-H1 Antigen, Antineoplastic Agents, Immunological, Nivolumab, Risk Factors, Neoplasms, [SDV.EE.SANT] Life Sciences [q-bio]/Ecology, environment/Health, Humans, CTLA-4 Antigen, Female, Immunosuppressive Agents, Aged
Aged, 80 and over, Graft Rejection, Male, Graft Survival, Programmed Cell Death 1 Receptor, Antibodies, Monoclonal, Middle Aged, Antibodies, Monoclonal, Humanized, Ipilimumab, Kidney Transplantation, B7-H1 Antigen, Antineoplastic Agents, Immunological, Nivolumab, Risk Factors, Neoplasms, [SDV.EE.SANT] Life Sciences [q-bio]/Ecology, environment/Health, Humans, CTLA-4 Antigen, Female, Immunosuppressive Agents, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 21 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
